niacinamide - CISMeF

Preferred Label : niacinamide;

MeSH definition : An important compound functioning as a component of the coenzyme NAD. Its primary significance is in the prevention and/or cure of blacktongue and PELLAGRA. Most animals cannot manufacture this compound in amounts sufficient to prevent nutritional deficiency and it therefore must be supplemented through dietary intake.;

MeSH synonym : 3 pyridinecarboxamide; vitamin b 3; b3, vitamin; 3-Pyridinecarboxamide; Nicotinamide; vitamin pp; b 3, vitamin; vitamin b3;

CISMeF synonym : pharmagenix brand of niacinamide; niacinamide pharmagenix brand; jenapharm brand of niacinamide; niacinamide jenapharm brand; merck brand of niacinamide; niacinamide merck brand; astra brand of niacinamide; niacinamide astra brand;

DeCS synonym : Nicotins ureamid Jenapharm;

MeSH hyponym : nicotinsäureamid jenapharm; nicobion; papulex; enduramide; Jenapharm, Nicotinsäureamid;

MeSH CAS label : 3-pyridinecarboxamide;

MeSH Related Number : 98-92-0 (Niacinamide);

Registry Number MeSH : 98-92-0;

MeSH annotation : /defic: consider also PELLAGRA; /ther use: coordinate disease with /drug ther, not /diet ther;

Wikipedia link : https://en.wikipedia.org/wiki/Nicotinamide;

Codes EINECS : 202-713-4;

Is substance : O;

medicament (CISMeF) : O;

UNII : 25X51I8RD4;

InChIKey : DFPAKSUCGFBDDF-UHFFFAOYSA-N;

Details

Origin ID

D009536;

UMLS CUI

C0028027;

ATC code(s)
- nicotinamide [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Adenine [FMA entity]
- Ascorbic acid [MedDRA LLT]
- Niacin [NCIt concept]
- Niacinamide preparation (product) [Inactive SNOMED CT concept]
- Pantothenic acid (substance) [SNOMED CT concept]
- Vitamin [PASCAL descriptor]
- Vitamin [UMLS semantic type]
- Vitamin [NCIt concept]
- Vitamin (substance) [SNOMED CT concept]
- Vitamin A [PASCAL descriptor]
- Vitamin A [MedDRA Preferred Term]
- Vitamin D [MedDRA Preferred Term]
- Vitamin E [MedDRA Preferred Term]
- Vitamin K [MedDRA Preferred Term]
- acide icosa-5,8,11,14-tetraenoique [nom iupac français], icosa-5,8,11,14-tetraenoic acid [Substance BNPC]
- ascorbic acid [Substance BNPC]
- biotin [Substance BNPC]
- cholecalciferol [Substance BNPC]
- folic acid [Substance BNPC]
- niacin [SNOMED Notion]
- riboflavin [Substance BNPC]
- s-methylmethioninium chloride [Substance BNPC]
- vitamin a [Substance BNPC]
- vitamin a [SNOMED Notion]
- vitamin b, nos [SNOMED Notion]
- vitamin d [Substance BNPC]
- vitamin d, nos [SNOMED Notion]
- vitamin e [SNOMED Notion]
- vitamin k [ATC Code]
- vitamin k [Substance BNPC]
- vitamin k 3 [Substance BNPC]
- vitamin k, nos [SNOMED Notion]
- vitamin l [SNOMED Notion]
- vitamin u [SNOMED Notion]
- vitamin, nos [SNOMED Notion]
- vitamins [ATC Code]
- vitamins [ATC Code]
- vitamins [MedlinePlus Topic]
CISMeF manual mappings
- niacinamide [Substance BNPC]
Currated CISMeF NLP mapping
- Niacinamide [NCIt concept]
- Nicotinamide [ICD-11 Extension code]
- Nicotinamide [LOINC component]
- Nicotinamide [ICHI extension code]
- Nicotinamide (substance) [SNOMED CT concept]
- Vitamin B3 [LOINC component]
- Vitamin PP [ICD-11 Extension code]
- Vitamin PP [Substance BNPC]
- Vitamin PP [ICHI extension code]
- niacinamide [SNOMED Notion]
- vitamin PP [Artificial nutrition thesaurus concept]
False automatic mappings
- levocarnitine [Substance BNPC]
Pharmacological action(s)
- vitamin B complex [MeSH Descriptor]
Record concept(s)
- enduramide [MeSH concept]
- niacinamide [MeSH concept]
- nicobion [MeSH concept]
- nicotinsäureamid jenapharm [MeSH concept]
- papulex [MeSH concept]
Related MeSH Supplementary Concept(s)
- (18F)FNDP [MeSH Supplementary Concept]
- (4-(1H-indol-3-yl)piperidin-1-yl)(pyridin-3-yl)methanone [MeSH Supplementary Concept]
- 1,1'-trimethylenebisnicotinamide [MeSH Supplementary Concept]
- 1,4-dihydro-N-methylnicotinamide [MeSH Supplementary Concept]
- 1,4-dimethylnicotinamide [MeSH Supplementary Concept]
- 1-(1-nicotinoylpiperidin-4-yl)-3-(4-(trifluoromethoxy)phenyl)urea [MeSH Supplementary Concept]
- 1-(4'-(4''-acetamido-2''-sulphoanilino)-2'-sulphoanilino)-3-(3'-carboxamidopyridino)-2,4,6-sym-triazine-3-amine [MeSH Supplementary Concept]
- 1-benzyl-1,4-dihydronicotinamide dimer [MeSH Supplementary Concept]
- 1-benzylnicotinamide [MeSH Supplementary Concept]
- 1-benzylnicotinamide triflate [MeSH Supplementary Concept]
- 1-methyl-1,2,5,6-tetrahydropyridine-3-(N,N-diethylcarboxamide) [MeSH Supplementary Concept]
- 1-methyl-N'-(hydroxymethyl)nicotinamide [MeSH Supplementary Concept]
- 1-methylisonicotinamide [MeSH Supplementary Concept]
- 1C8 compound [MeSH Supplementary Concept]
- 2,2'-diselenobis(3-amidopyridine) [MeSH Supplementary Concept]
- 2-((2,4-dimethoxybenzyl)sulfinyl)-N-(4-pyridyl)nicotinamide [MeSH Supplementary Concept]
- 2-(1-(5-(cyclohexylcarbamoyl)-6-propylsulfanylpyridin-2-yl)-3-piperidyl)acetic acid [MeSH Supplementary Concept]
- 2-(1-benzylpiperidin-4-yl)amino-N-(3-chlorophenyl)nicotinamide [MeSH Supplementary Concept]
- 2-(3,5-bis(trifluoromethyl)phenylamino)-N-(2-(4-fluorophenylamino)pyridin-3-yl)nicotinamide [MeSH Supplementary Concept]
- 2-(4'-((3,5-dimethylpiperazin-1-yl)methyl)-2'-(morpholinomethyl)biphenyl-3-yloxy)-5-fluoro-N-(4-(2-hydroxy-5-methylbenzamido)cyclohexyl)nicotinamide [MeSH Supplementary Concept]
- 2-(5-(4-fluorophenylcarbamoyl)pyridin-2-ylsulfanylmethyl)phenylboronic acid [MeSH Supplementary Concept]
- 2-(7-(3,4-dimethoxyphenyl)imidazo(1,2-c)pyrimidin-5-ylamino)nicotinamide [MeSH Supplementary Concept]
- 2-(nicotinamide)-1,3,4-thiadiazole [MeSH Supplementary Concept]
- 2-(nicotinoylaminoethanesulfonylamino)pyridine [MeSH Supplementary Concept]
- 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide [MeSH Supplementary Concept]
- 2-chloronicotinamide [MeSH Supplementary Concept]
- 2-propylisonicotinamide [MeSH Supplementary Concept]
- 3,5-bis((2'-nitroxyethyl)aminocarbonyl)pyridine [MeSH Supplementary Concept]
- 3-chloro-N-((1-methylpiperidin-2-yl)(thiophen-3-yl)methyl)-4-(trifluoromethyl)picolinamide [MeSH Supplementary Concept]
- 4,4'-(1,6-hexamethylenedithio)bis(1-octylpyridinium) [MeSH Supplementary Concept]
- 4-(4-(trifluoromethyl)phenyl)-N-(6-fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-1,4,5,6-tetrahydro-3-pyridinecarboxamide [MeSH Supplementary Concept]
- 4-methylnicotinamide [MeSH Supplementary Concept]
- 4-phenoxynicotinamide [MeSH Supplementary Concept]
- 5,6-dichloro-N-(3-(2,3-dihydro-1H-cyclopenta(b)quinolin-9-ylamino)propyl)nicotinamide [MeSH Supplementary Concept]
- 5-((3-fluorophenyl)ethynyl)-N-(3-hydroxy-3-methylbutan-2-yl)picolinamide [MeSH Supplementary Concept]
- 5-(4-butoxy-3-chlorophenyl)-N-((2-morpholinopyridin-3-yl)methyl)nicotinamide [MeSH Supplementary Concept]
- 5-(4-chlorophenyl)-6-(cyclopropylmethoxy)-N-(2-hydroxycyclohexyl)-3-pyridinecarboxamide [MeSH Supplementary Concept]
- 5-(4-chlorophenyl)-N-(2-hydroxycyclohexyl)-6-(2-methoxyethoxy)-3-pyridinecarboxamide [MeSH Supplementary Concept]
- 5-amino-N-(3-((4-((4-methoxy-2-(trifluoromethyl)phenyl)amino)benzyl)carbamoyl)tetrahydrofuran-3-yl)nicotinamide [MeSH Supplementary Concept]
- 5-amino-N-(tert-butyl)-4-(3-(isonicotinamide)phenyl)-2-(methylthio)thieno(2,3-d)pyrimidine-6-carboxamide [MeSH Supplementary Concept]
- 5-chloro-6-(4-(1-(4-chlorobenzyl)piperidin-4-yl)-3-ethylpiperazin-1-yl)-N-ethylnicotinamide [MeSH Supplementary Concept]
- 5-methylnicotinamide [MeSH Supplementary Concept]
- 5-ribofuranosyl-3-(aminocarbonyl)-1-methylpyridinium [MeSH Supplementary Concept]
- 5-ribofuranosylnicotinamide [MeSH Supplementary Concept]
- 6-((3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy)-N-methyl-3-pyridinecarboxamide [MeSH Supplementary Concept]
- 6-(3,4-dihydro-1H-isoquinolin-2-yl)-N-(6-methylpyridin-2-yl)nicotinamide [MeSH Supplementary Concept]
- 6-(4-((3-fluorobenzyl)oxy)phenoxy)nicotinamide [MeSH Supplementary Concept]
- 6-(4-fluorophenyl)-2-methyl-N-(2-methylbenzothiazol-5-yl)nicotinamide [MeSH Supplementary Concept]
- 6-acetamido-N-(2-(8-cyano-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-4-yl)-2-methylpropyl)nicotinamide [MeSH Supplementary Concept]
- 6-bromo-7-hydroxycoumarin-4-ylmethylnicotinamide [MeSH Supplementary Concept]
- 6-dimethylaminonicotinamide [MeSH Supplementary Concept]
- 6-hydrazino-N-(9-(2,3-dihydro-1H-cyclopenta(b)quinolin-9-ylamino)nonyl)nicotinamide hydrochloride [MeSH Supplementary Concept]
- 6-hydroxynicotinamide [MeSH Supplementary Concept]
- 6-methyl-N-(1H-tetrazol-5-yl)-2-pyridinecarboxamide [MeSH Supplementary Concept]
- 6-methyl-N-(3-((3-(1-methylethoxy)propyl)carbamoyl)-1H-pyrazol-4-yl)pyridine-3-carboxamide [MeSH Supplementary Concept]
- 6-methylnicotinamide [MeSH Supplementary Concept]
- A-933548 [MeSH Supplementary Concept]
- AAT-008 [MeSH Supplementary Concept]
- AD 101 [MeSH Supplementary Concept]
- ALW-II-41-27 [MeSH Supplementary Concept]
- AZ-27 compound [MeSH Supplementary Concept]
- AZD6925 [MeSH Supplementary Concept]
- CD 832 [MeSH Supplementary Concept]
- CI 1044 [MeSH Supplementary Concept]
- FR 146801 [MeSH Supplementary Concept]
- FR 76830 [MeSH Supplementary Concept]
- GBT1118 [MeSH Supplementary Concept]
- GDC-0623 [MeSH Supplementary Concept]
- HSN608 [MeSH Supplementary Concept]
- JNJ-47965567 [MeSH Supplementary Concept]
- KDOAM-25 [MeSH Supplementary Concept]
- L 735286 [MeSH Supplementary Concept]
- LS 081 [MeSH Supplementary Concept]
- LS 82-556 [MeSH Supplementary Concept]
- LY 362884 [MeSH Supplementary Concept]
- LY2196044 [MeSH Supplementary Concept]
- ML327 compound [MeSH Supplementary Concept]
- N',N-bis(2-pyridinecarboxamide)-1,2-ethane [MeSH Supplementary Concept]
- N'-cyano-N-(3-(4-(pyridin-2-yl)piperazin-1-yl)propyl)isonicotinamidine [MeSH Supplementary Concept]
- N'-methyl-2-pyridone-5-carboxamide [MeSH Supplementary Concept]
- N(1)-ethylnicotinamide [MeSH Supplementary Concept]
- N(1)-hexylnicotinamide [MeSH Supplementary Concept]
- N(1)-methyl-4-pyridone-5-carboxamide [MeSH Supplementary Concept]
- N(1)-methylnicotinamide [MeSH Supplementary Concept]
- N,N'-hexamethylenebis(3-pyridinecarboxamide) [MeSH Supplementary Concept]
- N-(1-(4-methoxybenzenesulfonyl)-2,3-dihydro-1H-indol-7-yl)-1-oxyisonicotinamide [MeSH Supplementary Concept]
- N-(1-(4-methoxybenzenesulfonyl)-2,3-dihydro-1H-indol-7-yl)isonicotinamide [MeSH Supplementary Concept]
- N-(1-amino-1-oxo-3-phenylpropan-2-yl)-6-(thiophen-2-yl)nicotinamide [MeSH Supplementary Concept]
- N-(1H-tetrazol-5-yl)-4-methyl-6-(4-(methylamino)phenyl)-2-pyridinecarboxamide [MeSH Supplementary Concept]
- N-(2,3-dihydroxypropyl)-1-((2-fluoro-4-iodophenyl)amino)isonicotinamide [MeSH Supplementary Concept]
- N-(2-(((1-phenyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)carbonyl)amino)ethyl)-6-(2,2,2-trifluoroethoxy)pyridine-3-carboxamide [MeSH Supplementary Concept]
- N-(2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl)-6-fluoronicotinamide [MeSH Supplementary Concept]
- N-(2-(3,5-di-tert-butyl-4-hydroxyphenyl)-4-oxo-thiazolidin-3-yl)-nicotinamide [MeSH Supplementary Concept]
- N-(2-(4-(2,3-dihydrobenzo(1,4)dioxin-2-ylmethyl)-(1,4)diazepan-2-yl)ethyl)-2-phenoxynicotinamide [MeSH Supplementary Concept]
- N-(2-(4-methoxyphenyl)-4-oxothiazolidin-3-yl)nicotinamide [MeSH Supplementary Concept]
- N-(2-(diethylamino)ethyl)-6-fluoronicotinamide [MeSH Supplementary Concept]
- N-(2-hydroxyethyl)-2-(methylsulfanyl)nicotinamide dihydrate [MeSH Supplementary Concept]
- N-(2-hydroxyethyl)nicotinamide [MeSH Supplementary Concept]
- N-(2-hydroxynaphthalen-1-yl)methylene)nicotinohydrazide [MeSH Supplementary Concept]
- N-(3-(1H-benzimidazol-2-yl)-4-chlorophenyl)pyridine-3-carboxamide [MeSH Supplementary Concept]
- N-(3-aminobenzyl)-6-(4-((3-fluorobenzyl)oxy)phenoxy)nicotinamide [MeSH Supplementary Concept]
- N-(4-((2-((cyclopropylcarbonyl)amino)imidazo(1,2-a)pyridin-6-yl)oxy)-3-fluorophenyl)-6-methyl-2-oxo-1-phenyl-1,2-dihydropyridine-3-carboxamide [MeSH Supplementary Concept]
- N-(4-((2-(2-(naphthaen-1-yl)acetamido)ethyl)carbamoyl)piperidin-4-yl)-6-(trifluoromethyl)nicotinamide [MeSH Supplementary Concept]
- N-(4-(1-(4-bromoindazole))phenyl)-N'-(4-chloro-3-trifluoromethylphenyl)urea [MeSH Supplementary Concept]
- N-(4-(2-(4'-((3,5-dimethylpiperazin-1-yl)methyl)-2'-(morpholinomethyl)biphenyl-3-yloxy)-5-fluoronicotinamido)cyclohexyl)-4-methylthiazole-2-carboxamide [MeSH Supplementary Concept]
- N-(4-fluoro-2-methylphenyl)-3-methyl-N-((2-methyl-1H-indol-4-yl)methyl)isonicotinamide [MeSH Supplementary Concept]
- N-(4-methoxy-7-methylbenzo(d)thiazol-2-yl)isonicatinamide [MeSH Supplementary Concept]
- N-(4-pyridyl)isonicotinamide [MeSH Supplementary Concept]
- N-(5-(2-(2,2-dimethylpyrrolidin-1-yl)ethylcarbamoyl)-2-methylpyridin-3-yl)-6-(1-methyl-1H-pyrazol-4-yl)pyrazolo(1,5-a)pyridine-3-carboxamide [MeSH Supplementary Concept]
- N-(5-(5-nitro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)4-oxo-2-thioxo-1,3-thiazolidin-3-yl)nicotinamide [MeSH Supplementary Concept]
- N-(6-chloro-7-methoxy-9H-beta-carbolin-8-yl)-2-methylnicotinamide [MeSH Supplementary Concept]
- N-(N-((3-cyanophenyl)sulfonyl)-4-cyclobutylaminoprolyl)-4-((3',5'-dichloroisonicotinoyl)amino)phenylalanine [MeSH Supplementary Concept]
- N-(hydroxymethyl)nicotinamide [MeSH Supplementary Concept]
- N-cyanomethyl-2-chloroisonicotinamide [MeSH Supplementary Concept]
- N-cyclobutyl-6-((3-fluorophenyl)ethynyl)nicotinamide [MeSH Supplementary Concept]
- N-cyclohexyl-2-(methylsulfanyl)nicotinamide [MeSH Supplementary Concept]
- N-ethylnicotinamide [MeSH Supplementary Concept]
- N-isopropyl-2-(methylsulfanyl)nicotinamide [MeSH Supplementary Concept]
- N-methyl-1,4-dihydronicotinamide [MeSH Supplementary Concept]
- N-methylnicotinamide [MeSH Supplementary Concept]
- N-nicotinoyl dopamine [MeSH Supplementary Concept]
- PFC-Kyoto solution [MeSH Supplementary Concept]
- PSMA-1007 [MeSH Supplementary Concept]
- Pristine (fungicide) [MeSH Supplementary Concept]
- RK-9123016 [MeSH Supplementary Concept]
- S(2) complex [MeSH Supplementary Concept]
- SBI-425 [MeSH Supplementary Concept]
- SG 103 [MeSH Supplementary Concept]
- SG 1842 [MeSH Supplementary Concept]
- SG 209 [MeSH Supplementary Concept]
- SG 212 [MeSH Supplementary Concept]
- SRPIN340 [MeSH Supplementary Concept]
- ST 71 [MeSH Supplementary Concept]
- ST 82 [MeSH Supplementary Concept]
- ST 90 [MeSH Supplementary Concept]
- SX-576 [MeSH Supplementary Concept]
- T 86 [MeSH Supplementary Concept]
- TAI-1 compound [MeSH Supplementary Concept]
- TAK-259 [MeSH Supplementary Concept]
- UC2288 [MeSH Supplementary Concept]
- V 3703 [MeSH Supplementary Concept]
- WY 27587 [MeSH Supplementary Concept]
- amoxicillin, ascorbic acid, niacinamide, riboflavin, thiamine drug combination [MeSH Supplementary Concept]
- anticataracticum [MeSH Supplementary Concept]
- asciminib [MeSH Supplementary Concept]
- ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium D-pantothenate drug combination [MeSH Supplementary Concept]
- aspernigrin C [MeSH Supplementary Concept]
- benzyldihydronicotinamide [MeSH Supplementary Concept]
- coamid [MeSH Supplementary Concept]
- cytoflavin [MeSH Supplementary Concept]
- diflufenican [MeSH Supplementary Concept]
- dihydronicotinamide [MeSH Supplementary Concept]
- dodecylnicotinamide [MeSH Supplementary Concept]
- flonicamid [MeSH Supplementary Concept]
- gelum oral-rd [MeSH Supplementary Concept]
- glunicate [MeSH Supplementary Concept]
- hepasteril [MeSH Supplementary Concept]
- homocysteine-thiolactone-nicotinamide [MeSH Supplementary Concept]
- hydrazino nicotinamide [MeSH Supplementary Concept]
- hydrazinonictinamide [MeSH Supplementary Concept]
- imetelstat [MeSH Supplementary Concept]
- iodo-niacin [MeSH Supplementary Concept]
- isonicotinamide [MeSH Supplementary Concept]
- menadione nicotinamide bisulfite [MeSH Supplementary Concept]
- merestinib [MeSH Supplementary Concept]
- motesanib diphosphate [MeSH Supplementary Concept]
- motesanib diphosphate [MeSH Supplementary Concept]
- niaprazine [MeSH Supplementary Concept]
- nicaraven [MeSH Supplementary Concept]
- nicomide [MeSH Supplementary Concept]
- nicotinamide N(1)-(N-(6-aminohexyl)acetamide)agarose [MeSH Supplementary Concept]
- nicotinamide N-oxide [MeSH Supplementary Concept]
- nicotinamide ribose-5'-methyl phosphate [MeSH Supplementary Concept]
- nicotinamide-beta-riboside [MeSH Supplementary Concept]
- nicotinamido-4-bis(2-chloroethyl)aminobenzaldimine [MeSH Supplementary Concept]
- nicotinohydroxamic acid [MeSH Supplementary Concept]
- nifenazone [MeSH Supplementary Concept]
- peficitinib [MeSH Supplementary Concept]
- picafibrate [MeSH Supplementary Concept]
- ramixotidine [MeSH Supplementary Concept]
- succinimidyl 6-hydrazinonicotinate [MeSH Supplementary Concept]
- tetraaqua-di(nicotinamide) Zn(II)-saccharinate [MeSH Supplementary Concept]
- thionicotinamide [MeSH Supplementary Concept]
- trans-4-(4-(3-(4-chloro-3-trifluoromethylphenyl)-ureido)-cyclohexyloxy-pyridine-2-carboxylic acid methylamide [MeSH Supplementary Concept]
- tryptamide [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
- Vitamin [UMLS semantic type]
UMLS correspondences (same concept)
- Niacinamide [NCIt concept]
- Niacinamide preparation (product) [Inactive SNOMED CT concept]
- Nicotinamide [LOINC component]
- Nicotinamide (substance) [SNOMED CT concept]
- niacinamide [SNOMED Notion]
- niacinamide preparation [SNOMED Notion]
- nicotinamide [ATC Code]
Validated automatic mappings to BTNT
- nicotinamide [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients